Munck Wilson Mandala provides strategic life science legal counsel by implementing our teams real-world experience in the industry. Attorneys are qualified in a variety of fields such as medical, chemistry, physics, and nanotechnology. We provide in-depth knowledge pertaining to trademark, copywriting, intellectual property, trade secrets, and regulatory protocols.

With extensive experience, our team is equipped to handle all matters under the life science umbrella. We are incredibly proud to assist organizations pioneering cutting edge biotech and life-changing medical advancements with the legal expertise necessary to succeed.

With extensive experience, our team is equipped to handle all matters under the life science umbrella. We are incredibly proud to assist organizations pioneering cutting edge biotech and life-changing medical advancements with the legal expertise necessary to succeed.

Munck Wilson Mandala offers legal services that cater to each companies’ unique goals by providing general counsel as well as niche services to achieve organizational milestones such as regulatory assistance, intellectual property, trademark, and more.

The team is well-versed in matters involving the Food and Drug Administration (FDA), the Federal Trade Commission (FTC), and the Office of the Inspector General, helping to seamlessly manage evolving regulatory issues.

“We work with talented people and it’s remarkable to see how science and technology can improve the health and quality of people’s lives.  We appreciate having a law firm that understands entrepreneurs and the passion we have to make lives better.”

MWM client

Client Alerts

FDA Cracks Down on Compounded GLP-1 Advertising

By Merritt Westcott Background GLP-1 drugs were originally approved for diabetes but later gained separate FDA approvals for weight loss under new brand names and codes. These approvals allowed insurers to cover only the diabetes versions.  Both brands’ prices are near or above $1,000 per month. High demand led to FDA-declared shortages in 2022, allowing

| 2 minute read

Press Releases

Munck Wilson Mandala Names Merritt D. Westcott Chair of Firm’s Expanding Life Sciences Practice

Westcott has built her reputation as a go-to trial lawyer in high-stakes biotech and pharmaceutical patent disputes, representing clients across genetically engineered crops and food products, monoclonal antibodies, blood cell controls, MedTech devices, and both traditional and biosimilar pharmaceuticals under the Hatch-Waxman Act and the Biologics Price Competition and Innovation Act. “Merritt combines world-class legal

| 3 minute read

Press Releases

Munck Wilson Mandala welcomes life sciences partner Denise Mayfield

Mayfield focuses her practice on the drafting and prosecution of patents primarily in life science, chemistry, biotechnology, medical devices, and bio-electrical (sensor) technologies. She also creates and manages client patent portfolios, performs various due diligence services (pre- and post-litigation), prepares/negotiates technology licensing and other corporate agreements (collaborative research agreements, joint venture agreements, joint research and

| 2 minute read

Press Releases

Munck Wilson Mandala adds Partner and Scientific Advisor to Life Sciences Practice

Munck Wilson Mandala has added additional talent to its life sciences practice, offering a comprehensive legal solution for businesses at the forefront of biotechnology, pharmaceuticals, diagnostics and medical devices. The MWM life sciences group features a multidisciplinary team of attorneys and patent professionals with advanced degrees in genetics, molecular biology, chemistry, mechanical and electrical engineering,

| 2 minute read

Press Releases

Texas Lawyer Names William Munck a Texas Trailblazer

As a trailblazer, Munck was the first in his family to attend college and combined his computer science, electrical engineering, and mathematic skills with a law degree.  He was recruited heavily by Silicon Valley firms in the 90s but chose Texas to start his legal career.  Munck saw the potential that North Texas provided in

| 2 minute read